Skip to main content
SpringerLink
Log in

Effectiveness of analogs of the kappa opioid receptor antagonist (3R)-7-Hydroxy-N-((1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic) to reduce U50,488-induced diuresis and stress-induced cocaine reinstatement in rats

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

The kappa opioid receptor (KOR) antagonist, JDTic, was reported to prevent stress-induced reinstatement of cocaine-maintained responding and to have antidepressant-like effects.

Objectives

Our objectives were to determine whether analogs of JDTic retained KOR antagonist activity and whether an orally effective analog prevented footshock-induced cocaine reinstatement.

Methods

RTI-194 (i.g. 1–30 mg/kg, s.c. 0.3–10 mg/kg, and i.p. 30 mg/kg), RTI-212 (s.c. 0.3–10 mg/kg and i.p. 30 mg/kg), and RTI-230 (i.g. 3–30 mg/kg and i.p. 1–30 mg/kg) were evaluated for their ability to block diuresis induced by 10-mg/kg U50,488 in rats. RTI-194 was additionally evaluated i.g. (3–100 mg/kg) for its ability to prevent footshock-induced reinstatement of responding previously reinforced with 0.5-mg/kg/inf cocaine.

Results

RTI-194 significantly (p < 0.05) attenuated U50,488-induced diuresis when given i.g., s.c., and i.p. RTI-194s effectiveness increased 1 week following administration. RTI-212 was ineffective. RTI-230 was ineffective when given i.g., but blocked diuresis at 24 h and 8 days (1, 10, and 30 mg/kg), 15 days (10 and 30 mg/kg), 22 and 29 days (30 mg/kg) following i.p. administration. Footshock reinstated responding in vehicle—but not RTI-194 (30 and 100 mg/kg)-treated rats.

Conclusions

RTI-194 and RTI-230 are effective KOR antagonists, and RTI-194 is now included with JDTic as the only reported compounds capable of antagonizing the KOR following oral administration. The failure of stress to reinstate cocaine seeking in rats treated with RTI-194 is consistent with results reported with JDTic, although it had less efficacy in lowering response levels than JDTic, suggesting a diminished overall effectiveness relative to it.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

JDTic:

(3R)-7-Hydroxy-N-{(1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl}-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide

KOR:

kappa opioid receptor

nor-BNI:

nor-binaltorphimine

U50,488:

trans-3,4-Dichloro-N-methyl-N-(2-[1-pyrrolidinyl] cyclohexyl)benzeneacetamide

RTI-194:

RTI compound RTI-5989-194

RTI-212:

RTI compound RTI-5989-212

RTI-230:

RTI compound RTI-5989-230

i.g.:

intragastric

i.p.:

intraperitoneal

s.c.:

subcutaneous

References

  • Aldrich JV, Patkar KA, McLaughlin JP (2009) Zyklophin, a systemically active selective kappa opioid receptor peptide antagonist with short duration of action. Proc Natl Acad Sci USA 106(43):18396–401

    Article  CAS  PubMed  Google Scholar 

  • Beardsley PM, Howard JL, Shelton KL, Carroll FI (2005) Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats. Psychopharmacology (Berl) 183:1–9

    Article  Google Scholar 

  • Broadbear JH, Negus SS, Butelman ER, de Costa BR, Woods JH (1994) Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on kappa-opioid agonists in the mouse writhing assay. Psychopharmacology (Berl) 115:311–319

    Article  CAS  Google Scholar 

  • Brooks DP, Giardina G, Gellai M, Dondio G, Edwards RM, Petrone G, DePalma PD, Sbacchi M, Jugus M, Misiano P et al (1993) Opiate receptors within the blood–brain barrier mediate kappa agonist-induced water diuresis. J Pharmacol Exp Ther 266:164–171

    CAS  PubMed  Google Scholar 

  • Bruchas MR, Yang T, Schreiber S, Defino M, Kwan SC, Li S, Chavkin C (2007) Long-acting kappa opioid antagonists disrupt receptor signaling and produce noncompetitive effects by activating c-Jun N-terminal kinase. J Biol Chem 282:29803–29811

    Article  CAS  PubMed  Google Scholar 

  • Bruchas MR, Land BB, Chavkin C (2009) The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors. Brain Res 1314:44–55

    Article  PubMed  Google Scholar 

  • Butelman ER, Negus SS, Ai Y, de Costa BR, Woods JH (1993) Kappa opioid antagonist effects of systemically administered nor-binaltorphimine in a thermal antinociception assay in rhesus monkeys. J Pharmacol Exp Ther 267:1269–1276

    CAS  PubMed  Google Scholar 

  • Cabral AM, Varner KJ, Kapusta DR (1997) Renal excretory responses produced by central administration of opioid agonists in ketamine and xylazine-anesthetized rats. J Pharmacol Exp Ther 282:609–616

    CAS  PubMed  Google Scholar 

  • Cai TB, Zou Z, Thomas JB, Brieaddy L, Navarro HA, Carroll FI (2008) Synthesis and in vitro opioid receptor functional antagonism of analogues of the selective kappa opioid receptor antagonist (3R)-7-hydroxy-N-((1S)-1-{[(3R, 4R)-4-(3-hydroxyphenyl)-3, 4-dimethyl-1-pipe ridinyl]methyl}-2-methylpropyl)-1, 2, 3, 4-tetrahydro-3-isoquinolinecarboxami de (JDTic). J Med Chem 51:1849–1860

    Article  CAS  PubMed  Google Scholar 

  • Carey AN, Borozny K, Aldrich JV, McLaughlin JP (2007) Reinstatement of cocaine place-conditioning prevented by the peptide kappa-opioid receptor antagonist arodyn. Eur J Pharmacol 569:84–89

    Article  CAS  PubMed  Google Scholar 

  • Carroll I, Thomas JB, Dykstra LA, Granger AL, Allen RM, Howard JL, Pollard GT, Aceto MD, Harris LS (2004) Pharmacological properties of JDTic: a novel kappa-opioid receptor antagonist. Eur J Pharmacol 501:111–119

    Article  CAS  PubMed  Google Scholar 

  • Cueva JP, Cai TB, Mascarella SW, Thomas JB, Navarro HA, Carroll FI (2010) Synthesis and in vitro opioid receptor functional antagonism of methyl-substituted analogues of (3R)-7-Hydroxy-N-[(1S)-1-{[(3R, 4R)-4-(3-hydroxyphenyl)-3, 4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl]-1, 2, 3, 4-tetrahydro-3-isoquinolinecarboxamide (JDTic). Journal of Medicinal Chemistry 52(23):7463–72

    Article  Google Scholar 

  • Endoh T, Matsuura H, Tanaka C, Nagase H (1992) Nor-binaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo. Arch Int Pharmacodyn Ther 316:30–42

    CAS  PubMed  Google Scholar 

  • Horan P, Taylor J, Yamamura HI, Porreca F (1992) Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test. J Pharmacol Exp Ther 260:1237–1243

    CAS  PubMed  Google Scholar 

  • Jewett DC, Woods JH (1995) Nor-binaltorphimine: an ultra-long acting kappa-opioid antagonist in pigeons. Behav Pharmacol 6:815–820

    CAS  PubMed  Google Scholar 

  • Jewett DC, Grace MK, Jones RM, Billington CJ, Portoghese PS, Levine AS (2001) The kappa-opioid antagonist GNTI reduces U50, 488-, DAMGO-, and deprivation-induced feeding, but not butorphanol- and neuropeptide Y-induced feeding in rats. Brain Res 909:75–80

    Article  CAS  PubMed  Google Scholar 

  • Jones DN, Holtzman SG (1992) Long term kappa-opioid receptor blockade following nor-binaltorphimine. Eur J Pharmacol 215:345–348

    Article  CAS  PubMed  Google Scholar 

  • Katoh A, Nabeshima T, Kameyama T (1990) Behavioral changes induced by stressful situations: effects of enkephalins, dynorphin, and their interactions. J Pharmacol Exp Ther 253:600–607

    CAS  PubMed  Google Scholar 

  • Ko MC, Willmont KJ, Lee H, Flory GS, Woods JH (2003) Ultra-long antagonism of kappa opioid agonist-induced diuresis by intracisternal nor-binaltorphimine in monkeys. Brain Res 982:38–44

    Article  CAS  PubMed  Google Scholar 

  • Kreek MJ (1987) Multiple drug abuse patterns and medical consequences. In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven, New York, pp 1597–1604

    Google Scholar 

  • Land BB, Bruchas MR, Lemos JC, Xu M, Melief EJ, Chavkin C (2008) The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system. J Neurosci 28:407–414

    Article  CAS  PubMed  Google Scholar 

  • Land BB, Bruchas MR, Schattauer S, Giardino WJ, Aita M, Messinger D, Hnasko TS, Palmiter RD, Chavkin C (2009) Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking. Proc Natl Acad Sci U S A 106(45):19168–73

    Article  CAS  PubMed  Google Scholar 

  • Leander JD (1983) A kappa opioid effect: increased urination in the rat. J Pharmacol Exp Ther 224:89–94

    CAS  PubMed  Google Scholar 

  • McLaughlin JP, Marton-Popovici M, Chavkin C (2003) Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses. J Neurosci 23:5674–5683

    CAS  PubMed  Google Scholar 

  • McLaughlin JP, Li S, Valdez J, Chavkin TA, Chavkin C (2006) Social defeat stress-induced behavioral responses are mediated by the endogenous kappa opioid system. Neuropsychopharmacology 31:1241–1248

    Article  CAS  PubMed  Google Scholar 

  • Menendez L, Andres-Trelles F, Hidalgo A, Baamonde A (1993) Involvement of spinal kappa opioid receptors in a type of footshock induced analgesia in mice. Brain Res 611:264–271

    Article  CAS  PubMed  Google Scholar 

  • Negus SS, Mello NK, Linsenmayer DC, Jones RM, Portoghese PS (2002) Kappa opioid antagonist effects of the novel kappa antagonist 5′-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys. Psychopharmacology (Berl) 163:412–419

    Article  CAS  Google Scholar 

  • Portoghese PS, Lipkowski AW, Takemori AE (1987) Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists. Life Sci 40:1287–1292

    Article  CAS  PubMed  Google Scholar 

  • Redila VA, Chavkin C (2008) Stress-induced reinstatement of cocaine seeking is mediated by the kappa opioid system. Psychopharmacology (Berl) 200:59–70

    Article  CAS  Google Scholar 

  • Shelton KL, Beardsley PM (2005) Interaction of extinguished cocaine-conditioned stimuli and footshock on reinstatement. Int J Comp Psychol 18:154–166

    Google Scholar 

  • Shelton KL, Hendrick E, Beardsley PM (2004) Interaction of noncontingent cocaine and contingent drug-paired stimuli on cocaine reinstatement. Eur J Pharmacol 497:35–40

    Article  CAS  PubMed  Google Scholar 

  • Takahashi M, Senda T, Tokuyama S, Kaneto H (1990) Further evidence for the implication of a kappa-opioid receptor mechanism in the production of psychological stress-induced analgesia. Jpn J Pharmacol 53:487–494

    Article  CAS  PubMed  Google Scholar 

  • Thomas JB, Atkinson RN, Rothman RB, Fix SE, Mascarella SW, Vinson NA, Xu H, Dersch CM, Lu Y, Cantrell BE, Zimmerman DM, Carroll FI (2001) Identification of the first trans-(3R, 4R)-dimethyl-4-(3-hydroxyphenyl)piperidine derivative to possess highly potent and selective opioid kappa receptor antagonist activity. J Med Chem 44:2687–2690

    Article  CAS  PubMed  Google Scholar 

  • Thomas JB, Atkinson RN, Vinson NA, Catanzaro JL, Perretta CL, Fix SE, Mascarella SW, Rothman RB, Xu H, Dersch CM, Cantrell BE, Zimmerman DM, Carroll FI (2003) Identification of (3R)-7-hydroxy-N-((1S)-1-[[(3R, 4R)-4-(3-hydroxyphenyl)-3, 4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl)-1, 2, 3, 4-tetrahydro-3-isoquinolinecarboxamide as a novel potent and selective opioid kappa receptor antagonist. J Med Chem 46:3127–3137

    Article  CAS  PubMed  Google Scholar 

  • Thomas JB, Fix SE, Rothman RB, Mascarella SW, Dersch CM, Cantrell BE, Zimmerman DM, Carroll FI (2004) Importance of phenolic address groups in opioid kappa receptor selective antagonists. J Med Chem 47:1070–1073

    Article  CAS  PubMed  Google Scholar 

  • Tortella FC, Echevarria E, Lipkowski AW, Takemori AE, Portoghese PS, Holaday JW (1989) Selective kappa antagonist properties of nor-binaltorphimine in the rat MES seizure model. Life Sci 44:661–665

    Article  CAS  PubMed  Google Scholar 

  • Valdez GR, Platt DM, Rowlett JK, Ruedi-Bettschen D, Spealman RD (2007) Kappa agonist-induced reinstatement of cocaine seeking in squirrel monkeys: a role for opioid and stress-related mechanisms. J Pharmacol Exp Ther 323:525–533

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology and Toxicology, School of Medicine, Virginia Commonwealth University, Richmond, VA, USA

    Patrick M. Beardsley

  2. VCU Institute for Drug and Alcohol Studies, Richmond, VA, USA

    Patrick M. Beardsley

  3. Howard Associates, LLC, Research Triangle Park, NC, USA

    Gerald T. Pollard & James L. Howard

  4. Organic and Medicinal Chemistry, Research Triangle Institute, Research Triangle Park, NC, USA

    F. Ivy Carroll

Authors
  1. Patrick M. Beardsley
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gerald T. Pollard
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. James L. Howard
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F. Ivy Carroll
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Patrick M. Beardsley.

Additional information

This research was supported by the National Institute on Drug Abuse, U19 DA021002.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Beardsley, P.M., Pollard, G.T., Howard, J.L. et al. Effectiveness of analogs of the kappa opioid receptor antagonist (3R)-7-Hydroxy-N-((1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic) to reduce U50,488-induced diuresis and stress-induced cocaine reinstatement in rats. Psychopharmacology 210, 189–198 (2010). https://doi.org/10.1007/s00213-010-1846-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-010-1846-3

Keywords

Search

Navigation